Generative AI is more efficient than nature at designing proteins to edit the genome

Dimitrije Ivančić (co-first author of the paper), Avencia Sanchez-Mejías (CEO of Integra Therapeutics), Alejandro Agudelo (co-first author of the paper) and Marc Güell (ICREA researcher and CSO of Integra Therapeutics)

Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences (MELIS) and the Center for Genomic Regulation (CRG), have designed and experimentally validated new synthetic proteins that can edit the human genome more efficiently than proteins provided by nature. This work, a global pioneer published today in […]